Burhan Turgut - Concepedia

Author

Burhan Turgut

Also Known As

B Turgut, B. Turgut, BURHAN TURGUT, Banu Turgut, Burak Turgut, Burhan TURGUT, Burhan Turgut, Celalettin Camcı, Mehmet Ali Erkurt, PAMUK, GÜLSÜM EMEL

121

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Trakya University Tekirdağ Namık Kemal University Inonu University Ministry of Health Sakarya University

About

Burhan Turgut is an author at Trakya University specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	913
2	Public Health	5	5	276
3	Health Sciences	4	4	154
4	Allergy	1	1	36
5	Cell Biology	1	1	38

Burhan Turgut

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The outcome of COVID‐19 in patients with hematological malignancy Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş, Journal of Medical Virology Hematological MalignancyLymphoid NeoplasiaIntensive Care UnitPediatric HematologyMedicine	2020	129
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, The Lancet ThrombopoiesisAutoimmune DiseaseBlood PlateletPrimary Immune ThrombocytopeniaImmunology	2023	77
Increased circulating platelet–neutrophil, platelet–monocyte complexes, and platelet activation in patients with ulcerative colitis: A comparative study Gülsüm Emel Pamuk, Özden Vural, Burhan Turgut, American Journal of Hematology Healthy SubjectsImmunologyGastroenterologyPathologyPlatelet–monocyte Complexes	2006	73
Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis? Gülsüm Emel Pamuk, Özden Vural, Burhan Turgut, Platelets Vascular DiseaseImmunologyPathologyInflammatory ArthritisInflammation	2008	65
The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein Sibel Güldiken, Muzaffer Demir, Ender Arıkan, Thrombosis Research InflammationSoluble Cd40 LigandVascular DiseaseEpidemiologyBody Mass Index	2006	65
Convalescent plasma therapy in patients with COVID-19 Fevzi Altuntaş, Naim Ata, Tuğçe Nur Yiğenoğlu, Transfusion and Apheresis Science Covid-19 PandemicConvalescent Plasma TherapyCovid-19 EpidemiologyMedicineCovid-19	2020	65
Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study Leylagül Kaynar, Fevzi Altuntaş, Ismet Aydogdu, Transfusion and Apheresis Science Neurodegenerative DiseasesNeurologic DiseasesClinical NeurologyClinical TrialsRetrospective Multicenter Study	2008	60
Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct Babürhan Güldiken, Sibel Güldiken, Burhan Turgut, Thrombosis Research ThrombosisVascular DiseaseCardiovascular DiseaseMedicineCerebrovascular Disease	2007	41
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors Semih Başçı, Naim Ata, Fevzi Altuntaş, Journal of Oncology Pharmacy Practice	2020	40
17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis Burhan Turgut, Özden Vural, Funda Sibel Pala, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyB-cll CellsVitro Fludarabine-induced ApoptosisSlight Spontaneous ResistanceApoptosis	2007	38

Page 1